W. Hashimoto

发表

Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12.

K. Takeda, K. Sugiura, K. Ogasawara, 1995, Journal of immunology.

Antimetastatic effect of NK1+ T cells on experimental haematogenous tumour metastases in the liver and lungs of mice

H. Watanabe, K. Takeda, Hisami Watanabe, 1997, Immunology.

Interleukin-12 Administration Is More Effective for Preventing Metastasis than for Inhibiting Primary Established Tumors in a Murine Model of Spontaneous Hepatic Metastasis

K. Takeda, K. Shiiba, S. Matsuno, 2002, Surgery Today.

Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.

H. Okamura, M. Lotze, P. Robbins, 2000, Cancer research.

Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis.

K. Takeda, K. Sugiura, K. Ogasawara, 1996, Journal of immunology.

Potent antitumor effects mediated by local expression of the mature form of the interferon-γ inducing factor, interleukin-18 (IL-18)

H. Okamura, M. Kurimoto, M. Lotze, 1999, Gene Therapy.

Interleukin‐12 induces cytotoxic NK1+αβ T cells in the lungs of euthymic and athymic mice

K. Takeda, K. Sugiura, S. Seki, 1996 .

Differential age-change in the numbers of CD4+CD45RA+ DC4+CD29+ T cell subsets in human peripheral blood

K. Hirokawa, M. Utsuyama, Kenshi Suzuki, 1992, Mechanisms of Ageing and Development.

Adjuvant immunotherapy using fibroblasts genetically engineered to secrete interleukin 12 prevents recurrence after surgical resection of established tumors in a murine adenocarcinoma model.

K. Kato, H. Hamada, K. Takeda, 1999, Surgery.

Interleukin-12 as an inducer of cytotoxic effectors in anti-tumor immunity.

K. Ogasawara, K. Kumagai, S. Seki, 1997, International reviews of immunology.

Involvement of NK1+ T Cells and Their IFN-γ Production in the Generalized Shwartzman Reaction

M. Obinata, K. Takeda, R. Okuyama, 1998, The Journal of Immunology.

Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.

H. Okamura, M. Kurimoto, M. Lotze, 1999, Journal of immunology.

Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2.

K. Takeda, K. Ogasawara, K. Kumagai, 1996, Journal of immunology.

Involvement of NK1+ T cells and their IFN-gamma production in the generalized Shwartzman reaction.

M. Obinata, K. Takeda, R. Okuyama, 1998, Journal of immunology.

LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells.

K. Takeda, K. Ogasawara, K. Kumagai, 1996, Journal of immunology.

Natural Killer Cells Lymphocytes by Interleukin 18 Using Dendritic Cells and Rapid Generation of Potent and Tumor-specific Cytotoxic T Updated

H. Okamura, M. Lotze, P. Robbins, 2000 .

Natural killer, but not natural killer T, cells play a necessary role in the promotion of an innate antitumor response induced by IL‐18

H. Okamura, M. Lotze, M. Taniguchi, 2003, International journal of cancer.

TRAV7-2*02 Expressing CD8+ T Cells Are Responsible for Palladium Allergy

T. Narushima, K. Ogasawara, Tetsu Takahashi, 2017, International journal of molecular sciences.

Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL-18

M. Lotze, P. Robbins, H. Tahara, 2002, Gene Therapy.